Tag : AUTOIMMUNE RHEUMATIC DISEASES

  • RESEARCH SPOTLIGHT
    Breaking the myths: Consensus statements from local rheumatologists recommend covid-19 vaccination in patients with autoimmune rheumatic diseases

    The Hong Kong Society of Rheumatology (HKSR) published a set of consensus statements for Coronavirus Disease 2019 (COVID-19) vaccination in adult patients with autoimmune rheumatic diseases (ARDs). This statement serves as a guide to local rheumatologists and other specialists, nurses, healthcare professionals and the public regarding the use of COVID-19 vaccines in patients with ARDs. ARD is a group of chronic medical illness characterized by systemic inflammation, in which a dysregulated immune system causes damage or dysfunction to connective tissues and leads to various treatment-related complications and comorbidities. In the current COVID-19 pandemic, patients with pre-existing chronic health conditions are more prone to serious illness and mortality from the infection, arousing concerns among patients with ARDs regarding their suitability for the COVID-19 vaccination.

    doctor name

    Dr. So, Ho

    Assistant Professor, Division of Rheumatology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong

    doctor name

    Dr. Yip, Man-Lung Ronald

    Specialist in Rheumatology, Tung Wah Group of Hospitals

    doctor name

    The Hong Kong Society of Rheumatology

    So H, et al. The Hong Kong Society of Rheumatology Consensus Recommendations for COVID-19 Vaccination in Adult Patients with Autoimmune Rheumatic Diseases.